The National Institutes of Health’s Post

End of
Translation

Despite the fact that IV fluid therapy is one of the standard pillars of care for sepsis, it's not always a sure bet — in fact, as the authors outline in their paper, giving IV fluids can sometimes make sepsis worse. Which fluids to give, how much to give and when have been fiercely debated for years. The new JAMA article sums up the latest science on the phases of sepsis and how much IV fluid to give at each stage of treatment. Sepsis is an extreme response by the body to an infection, leading to a drop in blood pressure and thus a lack of oxygen circulation. Death occurs when oxygen-deprived organs such as the brain, kidneys or liver fail. Treatment almost always includes administering #intravenous #fluids, along with other interventions such as antibiotics and medications to boost blood pressure and oxygen delivery to tissues. The goal is to restore circulation without causing edema, or swelling, which can also be harmful to organs. #sepsis #ivtherapy Read more ⬇️

🔍 Many people continue to experience symptoms such as dyspnea, cough, and fatigue beyond the initial phase of the infection. Long COVID, or these post-acute sequelae of COVID-19 (PASC), affects survivors at all levels of disease severity, including younger adults, children, and individuals who were not hospitalized. At first glance, there are no specific physical findings, and individuals often struggle to find appropriate therapy. However, a visual inspection of the CT thorax is perfect. The post-processing of the CT by FLUIDDA, utilized by Medimprove, provides interesting insights into how long COVID impacts the distribution of blood in the small pulmonary vessels. The good news is that a pulmonary rehabilitation program can improve patients' physical fitness and quality of life. The quantified CT thorax after rehabilitation reveals a significant (re)opening of the affected airways, influencing the blood distribution in the small pulmonary vessels. This publication and rehabilitation was provided by the interdisciplinary team of Medimprove. 👏 Congratulations to authors Wendel Dierckx, Wilfried De Backer, Yinka De Meyer, Eline Lauwers, Erik Franck, Jan De Backer and Kris Ides. #covid #longcovid #lunghealth

Should we re-evaluate rehabilitation practices for patients who are critically ill after the COVID-19 pandemic? In our latest manuscript, we describe the process, challenges, and opportunities learned from rehabilitating patients with end-stage pulmonary disease from COVID-19 on extracorporeal membrane and mechanical ventilation support Article here: https://lnkd.in/eKjwVNri #occupationaltherapy #physicaltherapy #icurehab #rehabilitation #ecmo

This clinical update provides a detailed overview on the main causes of myocardial injury during the COVID-19 pandemic. https://lnkd.in/dvspsypE

Long-term Effects of COVID-19 on the Cardiopulmonary System in Adults and Children: Current Status and Questions to be Resolved by the NIH Long COVID may occur in at least 10% of subjects recovering from severe acute respiratory syndrome coronavirus-2 (SARS-Co-V-2) infection and is often associated with debilitating symptoms. Among the organ systems that might be involved in its pathogenesis, the respiratory and cardiovascular systems may be central to common complaints seen in survivors of COVID including fatigue, dyspnea, chest pain, cough, and exercise intolerance. Understand the exact symptomatology, causes, and effects of Long COVID on the heart and lungs may help to discover new therapies. To that end, the National Institutes of Health (NIH) is sponsoring a national study population of diverse volunteers to support large-scale studies on the long-term effects of COVID-19. #LongCOVIDResearch #CardiopulmonaryEffects #NIHStudy #SARSCoV2Recovery #RespiratoryHealth #CardiovascularHealth #LongTermImpacts #COVIDSurvivors #Symptomatology #ResearchQuestions #PublicHealthScience

#POCUS gained prominence as a key tool for diagnosing and monitoring #COVID19 patients. Learn how pulmonary POCUS continues to be instrumental in diagnosing a variety of lung conditions including pneumonia, bronchiolitis, acute respiratory distress syndrome and more. Read the blog 👉 https://bit.ly/2Yo67ql

Long-term lung issues and lower quality of life plague COVID-19 survivors, new study warns New research in Scientific Reports reveals that COVID-19 survivors, especially those who had severe or critical illness, face long-term lung complications and a reduced quality of life. The study recommends 6-monthly pulmonary function tests for these survivors to monitor for chronic lung damage. https://lnkd.in/evrzxYsn

More Investigation on Long-Term COVID-19 Effects 🦠 A recent study in Nature Portfolio's Nature Medicine titled "Long-term health consequences of COVID-19" by Ziyad Al-Aly and team delves into the aftermath of SARS-CoV-2 infection. Key insights: • 2-year follow-up of 138,818 infected individuals. • Elevated risks of various disorders, including pulmonary, cardiovascular, and gastrointestinal, even 2 years post-infection. • Hospitalized individuals face a significantly elevated risk of death throughout the 2-year period. Here is the original article: https://lnkd.in/gXb7vkJf It is clear that understanding these long-term effects is pivotal for future care strategies. #COVID19 #Research #NatureMedicine #veteransaffairs